(Q38817997)

6 September 2017

A novel epigenetic mechanism regulating hyaluronan production in pancreatic cancer cells (English)

1 reference

6 September 2017

1 reference

Shiro Kohi

1

1 reference

6 September 2017

Norihiro Sato

2

1 reference

6 September 2017

Xiao-Bo Cheng

3

1 reference

6 September 2017

Atsuhiro Koga

4

1 reference

6 September 2017

Aiichiro Higure

5

1 reference

6 September 2017

Keiji Hirata

6

1 reference

6 September 2017

20 November 2015

1 reference

Clinical & Experimental Metastasis

6 September 2017

1 reference

6 September 2017

33

1 reference

6 September 2017

3

1 reference

6 September 2017

225-230

1 reference

https://scigraph.springernature.com/pub.10.1007/s10585-015-9771-9

6 September 2017

0 references

cites work

Pancreatic cancer biology and genetics

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

The role of epigenetic alterations in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Tumor-stroma interactions in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Hyaluronan: from extracellular glue to pericellular cue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Prognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Effects of 5-aza-2'-deoxycytidine on matrix metalloproteinase expression and pancreatic cancer cell invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

DNA methylation is developmentally regulated for genes essential for cardiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Hyaluronan in tissue injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Targeting DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Pharmacological inhibition of DNA methylation induces proinvasive and prometastatic genes in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

The DNA hypomethylating agent, 5-aza-2'-deoxycytidine, enhances tumor cell invasion through a transcription-dependent modulation of MMP-1 expression in human fibrosarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10585-015-9771-9

Induction of Ley antigen by 5-aza-2'-deoxycytidine in association with differentiation and apoptosis in human pancreatic cancer cells

21 January 2018

1 reference

12 December 2020

Localisation of hyaluronate (HA) in primary tumors and nude mouse xenografts of human pancreatic carcinomas using a biotinylated HA-binding protein

1 reference

12 December 2020

Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition

1 reference

12 December 2020

Hyaluronan is a secretory product of human pancreatic adenocarcinoma cells.

1 reference

12 December 2020

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions

1 reference

12 December 2020

Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.

1 reference

12 December 2020

Tumor microenvironment and progression of pancreatic cancer.

1 reference

12 December 2020

10.1007/S10585-015-9771-9

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference